Dahl Baunwall, S. M., Andreasen, S. E., Hansen, M. M., Kelsen, J., Høyer, K., Rågård, N., Eriksen, L. L., Støy, S., Rubak, T. M. M., Damsgaard, E. M. S., Mikkelsen, S., Erikstrup, C., Dahlerup, J. F. & Hvas, C. L. (2022). Faecal microbiota transplantation for first or second Clostridioides difficile infection (EarlyFMT): a randomised, double-blind, placebo-controlled trial. The Lancet Gastroenterology and Hepatology, 7(12), 1083-1091. Advance online publication. https://doi.org/10.1016/S2468-1253(22)00276-X

Hammeken, L. H., Baunwall, S. M. D., Dahlerup, J. F., Hvas, C. L. & Ehlers, L. H. (2022). Health-related quality of life in patients with recurrent Clostridioides difficile infections. Therapeutic Advances in Gastroenterology, 15. https://doi.org/10.1177/17562848221078441

Ianiro, G., Mullish, B. H., Iqbal, T. H., Terveer, E. M., Baunwall, S. M. D., Link, A., Sokol, H., Kupcinskas, J., Masucci, L., Sanguinetti, M., Vehreschild, M. J. G. T., Hvas, C. L., Keller, J. J., Gasbarrini, A., Kujiper, E. J. & Cammarota, G. (2022). Minimising the risk of monkeypox virus transmission during faecal microbiota transplantation: recommendations from a European expert panel. The Lancet Gastroenterology and Hepatology, 7(11), 979-980. https://doi.org/10.1016/S2468-1253(22)00305-3

Keller, J. J., Ooijevaar, R. E., Hvas, C. L., Terveer, E. M., Lieberknecht, S. C., Högenauer, C., Arkkila, P., Sokol, H., Gridnyev, O., Mégraud, F., Kump, P. K., Nakov, R., Goldenberg, S. D., Satokari, R., Tkatch, S., Sanguinetti, M., Cammarota, G., Dorofeev, A., Gubska, O. ... Vehreschild, M. J. (2021). A standardised model for stool banking for faecal microbiota transplantation: a consensus report from a multidisciplinary UEG working group. United European Gastroenterology Journal, 9(2), 229-247. Advance online publication. https://doi.org/10.1177/2050640620967898

Baunwall, S. M. D., Dahlerup, J. F., Engberg, J. H., Erikstrup, C., Helms, M., Juel, M. A., Kjeldsen, J., Nielsen, H. L., Nilsson, A. C., Rode, A. A., Vinter-Jensen, L. & Hvas, C. L. (2021). Danish national guideline for the treatment of Clostridioides difficile infection and use of faecal microbiota transplantation (FMT). Scandinavian Journal of Gastroenterology, 56(9), 1056-1077. https://doi.org/10.1080/00365521.2021.1922749

Hammeken, L. H., Baunwall, S. M. D., Hvas, C. L. & Ehlers, L. H. (2021). Health economic evaluations comparing faecal microbiota transplantation with antibiotics for treatment of recurrent Clostridioides difficile infection: a systematic review. Health Economics Review, 11(1), Article 3. https://doi.org/10.1186/s13561-021-00301-7

Ianiro, G., Mullish, B. H., Hvas, C. L., Segal, J. P., Kuijper, E. J., Costello, S. P., Kelly, C. R., Allegretti, J. R., Fischer, M., Iqbal, T. H., Satokari, R., Kao, D., Prehn, J. V., Ng, S. C., Bibbò, S., Baunwall, S. M. D., Quraishi, M. N., Sokol, H., Zhang, F. ... Cammarota, G. (2021). SARS-CoV-2 vaccines and donor recruitment for FMT. The Lancet. Gastroenterology & hepatology, 6(4), 264-266. https://doi.org/10.1016/S2468-1253(21)00032-7

Cold, F., Baunwall, S. M. D., Dahlerup, J. F., Petersen, A. M., Hvas, C. L. & Hansen, L. H. (2021). Systematic review with meta-analysis: encapsulated faecal microbiota transplantation – evidence for clinical efficacy. Therapeutic Advances in Gastroenterology, 14. https://doi.org/10.1177/17562848211041004

Baunwall, S. M. D., Terveer, E. M., Dahlerup, J. F., Erikstrup, C., Arkkila, P., Vehreschild, M. JGT., Ianiro, G., Gasbarrini, A., Sokol, H., Kump, P. K., Satokari, R., De Looze, D., Vermeire, S., Nakov, R., Brezina, J., Helms, M., Kjeldsen, J., Rode, A. A., Kousgaard, S. J. ... Hvas, C. L. (2021). The use of Faecal Microbiota Transplantation (FMT) in Europe: A Europe-wide survey. The Lancet Regional Health - Europe, 9, Article 100181. https://doi.org/10.1016/j.lanepe.2021.100181

Keller, J. J., Vehreschild, M. J., Hvas, C. L., Jørgensen, S. M., Kupcinskas, J., Link, A., Mulder, C. J., Goldenberg, S. D., Arasaradnam, R., Sokol, H., Gasbarrini, A., Hoegenauer, C., Terveer, E. M., Kuijper, E. J. & Arkkila, P. (2020). Donated stool for faecal microbiota transplantation is not a drug, but guidance and regulation are needed. United European Gastroenterology Journal, 8(3), 353-354. https://doi.org/10.1177/2050640620910847

Hvas, C. L., Baunwall, S. M. D. & Erikstrup, C. (2020). Faecal microbiota transplantation: A life-saving therapy challenged by commercial claims for exclusivity. EClinicalMedicine, 24, Article 100436. https://doi.org/10.1016/j.eclinm.2020.100436

Jørgensen, S. M. D., Rubak, T. M. M., Damsgaard, E. M., Dahlerup, J. F. & Hvas, C. L. (2020). Faecal microbiota transplantation as a home therapy to frail older people. Age and Ageing, 49(6), 1093-1096. Advance online publication. https://doi.org/10.1093/ageing/afaa073

Bahl, M. I., Jørgensen, S. M. D., Skriver, A. H., Larsen, N. A., Wang, M., Licht, T. R., Dahlerup, J. F. & Hvas, C. L. (2020). Faecal microbiota transplantation for eradication of co-infection with Clostridioides difficile and extensively drug-resistant KPC-producing Klebsiella pneumoniae. Scandinavian Journal of Gastroenterology, 55(5), 626-630. Advance online publication. https://doi.org/10.1080/00365521.2020.1753806

Baunwall, S. M. D., Lee, M. M., Eriksen, M. K., Mullish, B. H., Marchesi, J. R., Dahlerup, J. F. & Hvas, C. L. (2020). Faecal microbiota transplantation for recurrent Clostridioides difficile infection: An updated systematic review and meta-analysis. EClinicalMedicine, 29-30, Article 100642. https://doi.org/10.1016/j.eclinm.2020.100642

Jørgensen, S. M. D., Hvas, C. L., Dahlerup, J. F., Mikkelsen, S., Ehlers, L., Hammeken, L. H., Licht, T. R., Bahl, M. I. & Erikstrup, C. (2019). Banking feces: a new frontier for public blood banks? Transfusion, 59(9), 2776-2782. Advance online publication. https://doi.org/10.1111/trf.15422

Dehlholm-Lambertsen, E., Hall, B. K., Jørgensen, S. M. D., Jørgensen, C. W., Jensen, M. E., Larsen, S., Jensen, J. S., Ehlers, L., Dahlerup, J. F. & Hvas, C. L. (2019). Cost savings following faecal microbiota transplantation for recurrent Clostridium difficile infection. Therapeutic Advances in Gastroenterology, 12, Article 1756284819843002. https://doi.org/10.1177/1756284819843002

Grosen, A. K., Povlsen, J., Lemming, L. E., Dahl Jørgensen, S. M., Dahlerup, J. F. & Hvas, C. L. (2019). Faecal Microbiota Transplantation Eradicated Extended-Spectrum Beta-Lactamase-Producing Klebsiella pneumoniae  from a Renal Transplant Recipient with Recurrent Urinary Tract Infections. Case Reports in Nephrology and Dialysis, 9(2), 102-107. https://doi.org/10.1159/000502336

Hvas, C. L., Jørgensen, S. M. D., Jørgensen, S. P., Storgaard, M., Lemming, L., Hansen, M. M., Erikstrup, C. & Dahlerup, J. F. (2019). Fecal Microbiota Transplantation is Superior to Fidaxomicin for Treatment of Recurrent Clostridium difficile Infection. Gastroenterology, 156(5), 1324-1332.e3. https://doi.org/10.1053/j.gastro.2018.12.019

Keller, J. J., Vehreschild, M. JGT., Hvas, C. L., Jørgensen, S. MD., Kupciskas, J., Link, A., Mulder, C. JJ., Goldenberg, S. D., Arasaradnam, R., Sokol, H., Gasbarrini, A., Hoegenauer, C., Terveer, E. M., Kuijper, E. J. & Arkkila, P. (2019). Stool for fecal microbiota transplantation should be classified as a transplant product and not as a drug. United European Gastroenterology Journal, 7(10), 1408-1410. https://doi.org/10.1177/2050640619887579

Hvas, C. L., Bendix, M., Dige, A., Dahlerup, J. F. & Agnholt, J. (2018). Current, experimental, and future treatments in inflammatory bowel disease: a clinical review. Immunopharmacology and Immunotoxicology, 40(6), 446-460. Advance online publication. https://doi.org/10.1080/08923973.2018.1469144

Hvas, C. L., Ott, P., Paine, P., Lal, S., Jørgensen, S. P. & Dahlerup, J. F. (2018). Obeticholic acid for severe bile acid diarrhea with intestinal failure: A case report and review of the literature. World Journal of Gastroenterology, 24(21), 2320-2326. https://doi.org/10.3748/wjg.v24.i21.2320

Dahl Jørgensen, S. M., Erikstrup, C., Dinh, K. M., Lemming, L. E., Dahlerup, J. F. & Hvas, C. L. (2018). Recruitment of feces donors among blood donors: Results from an observational cohort study. Gut Microbes, 9(6), 540-550. https://doi.org/10.1080/19490976.2018.1458179

Hvas, C. L., Farrer, K., Blackett, B., Lloyd, H., Paine, P. & Lal, S. (2018). Reduced 30-day gastrostomy placement mortality following the introduction of a multidisciplinary nutrition support team: a cohort study. Journal of Human Nutrition and Dietetics, 31(3), 413-421. Advance online publication. https://doi.org/10.1111/jhn.12520

Hvas, C. L., Borre, M. & Fassov, J. (2017). Ernæring og kosttilskud ved kronisk inflammatorisk tarmsygdom. Ugeskrift for Laeger, 179(22), 2-6. http://ugeskriftet.dk/videnskab/ernaering-og-kosttilskud-ved-kronisk-inflammatorisk-tarmsygdom

Jørgensen, S. M. D., Hansen, M. M., Erikstrup, C., Dahlerup, J. F. & Hvas, C. L. (2017). Faecal microbiota transplantation: establishment of a clinical application framework. European Journal of Gastroenterology and Hepatology, 29(11), 36-45. Advance online publication. https://doi.org/10.1097/MEG.0000000000000958

Hvas, C. L., Dige, A., Bendix Rasch, M., Wernlund, P. G., Christensen, L. A., Dahlerup, J. F. & Agnholt, J. (2016). Casein glycomacropeptide for active distal ulcerative colitis: a randomized pilot study. European Journal of Clinical Investigation, 46(6), 555-63. https://doi.org/10.1111/eci.12634

Oppfeldt, A. M., Dahlerup, J. F., Christensen, L. A. & Hvas, C. L. (2016). Faecal microbiota transplantation for recurring Clostridium difficile infection in a patient with Crohn's disease and ileorectal anastomosis. BMJ Case Reports, 2016. https://doi.org/10.1136/bcr-2016-217209

Hvas, C. L. (2016). Fæcestransplantation: afføring fra raske donorer som behandling af akutte og kroniske sygdomme. Maanedsskrift for Almen Praksis, 94(3), 203-211.

Ravnborg, A. B., Hvas, C. L., Agnholt, J., Dahlerup, J. F., Vind, I., Till, A., Rosenstiel, P. & Höllsberg, P. (2009). Toll-like receptor-induced granulocyte-macrophage colony-stimulating factor secretion is impaired in Crohn's disease by nucleotide oligomerization domain 2-dependent and -independent pathways. Clinical and Experimental Immunology, 155, 487-95.

Hvas, C. L., Kelsen, J., Agnholt, J., Höllsberg, P., Tvede, M., Møller, J. K. & Dahlerup, J. F. (2007). Crohn's disease intestinal CD4+ T cells have impaired interleukin-10 production which is not restored by probiotic bacteria. Scandinavian Journal of Gastroenterology, 42, 592-601.

Kelsen, J., Hvas, C. L., Agnholt, J. & Dahlerup, J. F. (2006). CD4⁺CD25⁺-regulatoriske T-celler og deres betydning for sygdomme hos mennesker. Ugeskrift for Laeger, 168, 32-7.